Frailty and the biochemical effects of recombinant human growth hormone in women after surgery for hip fracture

Growth Hormone and IGF Research

Volumn 13, Issue 6, 2003, Pages 361-370

  Yeo, A L ^a,d   Levy, D ^b,e   Martin, Finbarr C ^a   Sonksen P ^a   Sturgess, I ^c,g   Wheeler, M M ^a   Young, A ^b,f  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c Elderly Care Unit   (United Kingdom)

^d WORTHING HOSPITAL   (United Kingdom)

^e BARNET HOSPITAL   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g Canterbury Hospital   (United Kingdom)

Author keywords

Ageing; Body composition; Frailty; Growth hormone; Hip fractures; Insulin like growth factor I; Muscle strength

Indexed keywords

HUMAN GROWTH HORMONE; PLACEBO; SOMATOMEDIN C;

ACUTE KIDNEY FAILURE; AGED; ANKLE EDEMA; ARTHRALGIA; ARTICLE; BIOSYNTHESIS; BODY COMPOSITION; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEHYDRATION; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG FATALITY; DRUG MECHANISM; DRUG MEGADOSE; DYSPEPSIA; FEMALE; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL DISEASE; GERIATRIC DISORDER; GLUCOSE INTOLERANCE; HEART INFARCTION; HIP FRACTURE; HIP SURGERY; HUMAN; INSOMNIA; LIVER DYSFUNCTION; LOW DRUG DOSE; LUNG EMBOLISM; MUSCLE MASS; MUSCLE STRENGTH; MUSCULOSKELETAL DISEASE; OSTEOPOROSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RISK FACTOR; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 0344974069     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ghir.2003.08.001     Document Type: Article

References (50)

1. Anonymous. Fracture neck of femur: prevention and management. Summary and recommendations of a report of the Royal College of Physicians of London, J. R. Coll. Phys. 23 (1989) 8-12.
2. W.J. Boyce, M.P. Vessey, Rising incidence of fracture of the proximal femur, Lancet i (1985) 150-151.
3. K.J. Obrant, U. Benger, O. Johnell, B.E. Nilsson, I. Sembo, Increasing age-adjusted risk of fragility fractures: a sign of increasing osteoporosis in successive generations, Calcif. Tissue Int. 44 (1989) 157-167.
4. C.J. Todd, C.J. Freeman, C. Camilleri-Ferrante, et al., Differences in mortality after fracture of hip: the East Anglian audit, BMJ 310 (1995) 904-908.
5. J. Magaziner, E.M. Simonsich, T.M. Kashner, J.R. Hebel, J.E. Kenzora, Predictors of functional recovery one year following discharge for hip fracture: a prospective study, J. Gerontol. 45 (1990) 101-107.
6. M.R. Foster, R.B. Heppenstall, Z.B. Freidenburg, et al., A prospective assessment of nutritional status and complications in patients with fractures of the hip, J. Orthop. Trauma 4 (1990) 49-57.
7. D.P. Kiel, D.T. Felson, J.J. Anderson, P.W. Wilson, M.A. Moskowitz, Hip fractures and the use of estrogens in postmenopausal women. The Framingham Study, N. Engl. J. Med. 317 (1987) 1169-1174.
8. A. Aniansson, C. Zetterberg, M. Hedberg, K.G. Henriksson, Impaired muscle function with ageing. A background factor in the incidence of fractures of the proximal end of the femur, Clin. Orthop. Rel. Res. 191 (1984) 193-201.
9. S.K. Phillips, R.C. Woledge, S.A. Bruce, et al., A study of force and cross-sectional area of adductor pollicis muscle in female hip fracture patients, J. Am. Geriatr. Soc. 46 (8) (1998) 999-1002.
10. M.R. Gonzalez-Crespo, J. Arenas, J.J. Gomez-Reino, et al., Muscle dysfunction in elderly individuals with hip fracture, J. Rheumatol. 26 (10) (1999) 2229-2232.
11. K.M. Fox, W.G. Hawkes, J.R. Hebel, et al., Mobility after hip fracture predicts health outcomes, J. Am. Geriatr. Soc. 46 (2) (1998) 169-173.
12. K.J. Koval, S.G. Maurer, E.T. Su, G.B. Aharonoff, J.D. Zuckerman, The effects of nutritional status on outcome after hip fracture, J. Orthop. Trauma 13 (3) (1999) 164-169.
13. P.G. Stableforth, Supplementary feeds and nitrogen and calorie balance following femoral neck fracture, Br. J. Surg. 73 (1986) 651-655.
14. M.D. Bastow, J. Rawlings, S.P. Allison, Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial, Br. Med. J. 287 (1983) 1589-1592.
15. M. Delmi, C.H. Rapin, J.M. Bengoa, et al., Dietary supplementation in elderly patients with fractured neck of femur, Lancet 335 (1990) 1013-1016.
16. C.M. Williams, L.T. Driver, J. Older, J.W.T. Dickerson, A controlled trial of sip-fed supplements in elderly orthopaedic patients, Eur. J. Clin. Nutr. 43 (1993) 267-274.
17. A. Iranmanesh, G. Lizarralde, J.D. Veldhuis, Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men, J. Clin. Endocrinol. Metab. 73 (1991) 1081-1088.
18. K.G. OConnor, J.D. Tobin, S.M. Harman, et al., Serum levels of insulin-like growth factor -I are related to age and not to body composition in healthy women and men, J. Gerontol. 53A (1998) M176-182.
19. J.A. Langlois, C.J. Rosen, M. Visser, et al., Association between insulin-like growth factor-I and bone mineral density in older women and men: the Framingham Heart Study, J. Clin. Endocrinol. Metab. 83 (1998) 4257-4262.
20. M. Hedstrom, M. Saaf, N. Dalen, Low IGF-I levels in hip fracture patients. A comparison of 20 coxarthrotic and 23 hip fracture patients, Acta Orthopaed. Scand. 70 (2) (1999) 145-148.
21. D. Rudman, A.G. Feller, H.S. Nagraj, et al., Effects of human growth hormone in men over 60 years old, N. Engl. J. Med. 323 (1990) 1-6.
22. J.L. Thompson, G.E. Butterfield, R. Marcus, et al., The effects of recombinant human insulin-like growth factor I and growth hormone on body composition in elderly women, J. Clin. Endocrinol. Metab. 80 (6) (1995) 1845-1852.
23. M.A. Papadakis, D. Grady, D. Black, et al., Growth hormone replacement in healthy older men improves body composition but not functional ability, Ann. Int. Med. 124 (1996) 708-716.
24. K.S. Langford, J.P. Miell, The insulin-like growth factor-1/binding protein axis: physiology, pathophysiology and therapeutic manipulation, Eur. J. Clin. Invest. 23 (1993) 503-516.
25. M.A. Schurch, R. Rizzoli, D. Slosman, et al., Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial, Ann. Intern. Med. 128 (1998) 801-809.
26. L.-W. Chu, K.L.S. Lam, S.C.F. Tam, et al., A randomised controlled trial of low dose recombinant human growth hormone in the treatment of malnourished elderly medical patients, J. Clin. Endocrinol. Metab. 86 (2001) 1913-1920.
27. H.C. Ward, D. Halliday, J.W. Sim, Protein and energy metabolism with biosynthetic growth hormone after gastrointestinal surgery, Ann. Surg. 208 (1987) 56-61.
28. Z.M. Jiang, G.Z. He, S.Y. Zhang, et al., Low dose growth hormone and hypocaloric nutrition attenuate the protein catabolic response after major operation, Ann. Surg. 210 (1989) 513-524.
29. R. Ross, J. Miell, E. Freeman, et al., Critically ill patients have high basal growth hormone levels attenuated oscillatory activity associated with low levels of insulin-like growth factor-I, Clin. Endocrinol. 35 (1991) 47-54.
30. H.S. Soroff, R.R. Rozin, J. Mooty, J. Lister, M.S. Raben, Role of human growth hormone in the response to trauma. I. Metabolic effects following burns, Ann. Surg. 166 (1967) 739-752.
31. R.J. Hodes, Frailty and disability: can growth hormone or other trophic agents make a difference?, J. Am. Geriatr. Soc. 42 (1994) 1208-1211.
32. A.J. Van der Lely, S.W. Lamberts, K.W. Jauch, et al., Use of human GH in elderly patients with accidental hip fracture, Eur. J. Endocrinol. 143 (2000) 585-592.
33. H.M. Hodkinson, Evaluation of a mental test score for assessment of mental impairment in the elderly, Age Ageing 1 (1972) 233-238.
34. J.D. Teale, V. Marks, Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumour hypoglycaemia, Clin. Endocrinol. 33 (1990) 87-98.
35. S.C. Cwyfan Hughes, J.A.H. Wass, J.M.P. Holly, Two radioimmunoassays for IGFBP-3 using different site-specific antisera; divergence of which reflect the presence of circulating protease, J. Endocrinol. 135 (suppl.) (1992) P73.
36. J.M. Tanner, The measurement of body fat in man, Br. Nutr. Soc. 18 (1959) 148.
37. C. Collin, D.T. Wade, S. Davies, V. Home, The Barthel ADL index: a reliability study, Int. Disabil. Studies 10 (1988) 61-63.
38. F.I. Mahoney, D.W. Barthel, Functional evaluation: the Barthel index, Maryland State Med. J. 14 (1965) 61-64.
39. A.M. Cotterill, P. Mendel, J.M.P. Holly, et al., The differential regulation of the circulating levels of insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery, Clin. Endocrinol. 44 (1996) 91-101.
40. A.R. Lyons, Clinical outcomes and treatment of hip fractures, Am. J. Med. 103 (2A) (1997) 51S-63S.
41. J.O. Johansson, K. Landin, G. Johannsson, L. Tengborn, B.A. Bengtsson, Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults, Thromb. Haemost. 76 (3) (1996) 422-428.
42. P. Carroll, E.R. Christ (and the GRS Scientific Committee), Growth Hormone deficiency in Adulthood and the effects of Growth Hormone Replacement: A Review, J. Clin. Endocrinol. Metab. 83(2) (1998) 382-396.
43. E. Corpas, S.M. Harman, M.R. Blackman, Human growth hormone and human aging, Endocr. Rev. 14 (1) (1993) 20-39.
44. H. Brahm, K. Piehl-Aulin, B. Saltin, S. Ljunghall, Net fluxes over working thigh of hormones, growth factors, and biomarkers of bone metabolism during shortlasting dynamic exercise, Calcif. Tissue Int. 60 (1997) 175-180.
45. J.P. Thissen, L.E. Underwood, J.M. Ketelslegers, Regulation of insulin-like growth factor-I in starvation and injury, Nutr. Rev. 57 (6) (1999) 167-176.
46. T.J. Merimee, J. Zapf, E.R. Froesch, Insulin-like growth factors in fed and fasted states, J. Clin. Endocrinol. Metab. 55 (1982) 999-1002.
47. J.P. Thissen, J. Verniers, Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture, Endocrinology 138 (3) (1997) 1078-1084.
48. A.C. Timmins, A.M. Cotterill, S.C. Cwyfan Hughes, et al., Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease, Crit. Care Med. 24 (9) (1996) 1460-1466.
49. M. Davenport, W.L. Isley, J.B. Pucilowska, et al., Insulin-like growth factor binding protein-3 proteolysis is induced after elective surgery, J. Clin. Endocrinol. Metab. 75 (1992) 590-595.
50. T.B. Harris, D. Kiel, R. Roubenoff, et al., Association of Insulin-like growth factor I with body composition, weight history and past health behaviors in the very old: The Framingham heart study, J. Am. Geriatr. Soc. 45 (1997) 133-139.